---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-007823"
form_type: "8-K"
ticker: null
cik: "0000910267"
company_name: "TITAN PHARMACEUTICALS INC"
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:11:40.437635+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Titan Pharmaceuticals completes merger with Black Titan; shares to cease trading on Nasdaq

## Summary
- On Oct 1, 2025, Titan merged with Black Titan subsidiary; TTNP shares convert to PubCo ordinary shares.
- TalenTec shareholders contributed shares for PubCo shares; PubCo shares to start trading Oct 2 on Nasdaq.
- All TTNP directors and officers resigned; Chay Weei Jye appointed as sole director and acting secretary.

## SEC filing metadata
- accession: 0001829126-25-007823
- form_type: 8-K
- cik: 0000910267
- company_name: TITAN PHARMACEUTICALS INC
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.03, 5.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910267/000182912625007823/0001829126-25-007823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910267/000182912625007823/titanpharma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-007823
- JSON: https://secwatch.observer/filing/0001829126-25-007823.json
- Plain text: https://secwatch.observer/filing/0001829126-25-007823.txt

## Source-grounded claims
- claim_id: efd8625a5c4d68f0e0020fecd6a7c65a6e518264
  claim: TITAN PHARMACEUTICALS INC underwent a change of control involving Black Titan Corporation (closed 2025-10-01).
  evidence_excerpt: Upon the terms and subject to the conditions of the Merger Agreement, on October 1, 2025, at the effective time of the Merger (the “ Effective Time ”), Merger Sub merged with and into Parent (the “ Merger ”), with Parent continuing as the surviving corporation under the same name as a direct wholly owned subsidiary of Black Titan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/910267/000182912625007823/0001829126-25-007823-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
